A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Clinical trial NCT02678793 · COMPLETED

Trial details

NCT number: NCT02678793
Sponsor: Centrexion Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Morton's Neuroma

Start date: 2015-12-01
Primary completion: 2016-12-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.